tirzepatide cardiovascular outcomes trial In patients with type 2 diabetes and atherosclerotic disease, was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT 💡 New insight in diabetes

Women also have naturally slower gastric motility than men, which compounds the gastric slowing effect of GLP-1 activation

"Sometimes we find as many as six impossible things before breakfast" jci.org/articles/view/ How do GLP-1 medicines interact with immune cells to reduce #inflammation

10 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial

This is why diabetes is a condition of abnormally and consistently high blood sugars

Read the full article to see how advanced dressings are shaping the future of wound care: #woundcare #patientsafety #productdesign Advanced wound dressing platforms medical.averydennison.com To view or add a comment, sign in It has been a couple of weeks since we have posted on our work with CMS audits for skin substitutes: Noridian and CGS, cite this comment from the current LCDs for skin substitutes: "The fundamental basis for non-healing of a wound is of paramount importance and must be corrected prior to consideration of additional therapy." To wit, we say, CMS should require and reimburse for bioidentical hormone replacement for women suffering from chronic wounds